Barclays’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Sell
769,429
-1,828,888
-70% -$34.1M ﹤0.01% 1231
2026
Q1
$42.7M Buy
2,598,317
+987,615
+61% +$16.9M 0.01% 783
2025
Q4
$25.9M Buy
1,610,702
+115,177
+8% +$2.03M 0.01% 1096
2025
Q3
$28.6M Buy
1,495,525
+97,662
+7% +$1.75M 0.01% 1035
2025
Q2
$24.5M Buy
1,397,863
+87,595
+7% +$1.56M 0.01% 1021
2025
Q1
$26.5M Buy
1,310,268
+246,974
+23% +$5M 0.01% 895
2024
Q4
$21.6M Sell
1,063,294
-470,471
-31% -$10.2M 0.01% 1081
2024
Q3
$35.1M Sell
1,533,765
-34,196
-2% -$737K 0.01% 813
2024
Q2
$30.7M Sell
1,567,961
-684,261
-30% -$13.1M 0.01% 787
2024
Q1
$42.2M Sell
2,252,222
-1,685,432
-43% -$30.6M 0.01% 673
2023
Q4
$78M Buy
3,937,654
+2,186,871
+125% +$38.5M 0.03% 494
2023
Q3
$32.1M Sell
1,750,783
-825,794
-32% -$17M 0.02% 621
2023
Q2
$51.8M Buy
2,576,577
+1,415,873
+122% +$29.4M 0.03% 433
2023
Q1
$25.5M Sell
1,160,704
-586,897
-34% -$14.6M 0.01% 756
2022
Q4
$43.8M Buy
1,747,601
+489,827
+39% +$11.9M 0.02% 551
2022
Q3
$28.8M Buy
1,257,774
+414,354
+49% +$10.9M 0.03% 484
2022
Q2
$21.9M Buy
843,420
+274,540
+48% +$8.32M 0.01% 684
2022
Q1
$19.5M Buy
+568,880
New +$19.2M 0.02% 689
2019
Q4
Sell
-2,314,305
Closed -$82.5M 6432
2019
Q3
$82.5M Buy
2,314,305
+107,045
+5% +$3.61M 0.05% 294
2019
Q2
$70.6M Buy
2,207,260
+1,076,910
+95% +$33.5M 0.04% 372
2019
Q1
$35.4M Sell
1,130,350
-132,269
-10% -$4.03M 0.02% 562
2018
Q4
$35.3M Sell
1,262,619
-121,773
-9% -$3.37M 0.03% 505
2018
Q3
$36.4M Buy
1,384,392
+223,726
+19% +$5.88M 0.03% 551
2018
Q2
$30M Sell
1,160,666
-225,450
-16% -$5.32M 0.03% 582
2018
Q1
$32.2M Buy
1,386,116
+528,379
+62% +$12.3M 0.02% 617
2017
Q4
$22.4M Buy
857,737
+142,975
+20% +$3.79M 0.02% 748
2017
Q3
$19.9M Buy
714,762
+34,288
+5% +$1.03M 0.02% 674
2017
Q2
$21.7M Buy
680,474
+432,602
+175% +$13.7M 0.02% 566
2017
Q1
$7.75M Sell
247,872
-87,379
-26% -$2.68M 0.01% 1043
2016
Q4
$9.96M Sell
335,251
-292,558
-47% -$8.92M 0.01% 942
2016
Q3
$21.7M Sell
627,809
-475,453
-43% -$16.6M 0.02% 516
2016
Q2
$35.6M Sell
1,103,262
-9,877
-0.9% -$307K 0.05% 334
2016
Q1
$32.4M Sell
1,113,139
-313,282
-22% -$9.4M 0.05% 336
2015
Q4
$49.4M Buy
1,426,421
+362,597
+34% +$12.1M 0.06% 284
2015
Q3
$35.8M Sell
1,063,824
-19,047
-2% -$659K 0.04% 368
2015
Q2
$35.5M Sell
1,082,871
-239,901
-18% -$8.73M 0.04% 412
2015
Q1
$51.8M Buy
1,322,772
+31,026
+2% +$1.25M 0.06% 315
2014
Q4
$51.8M Buy
1,291,746
+69,120
+6% +$2.74M 0.05% 340
2014
Q3
$43.4M Sell
1,222,626
-1,075,884
-47% -$40.8M 0.04% 377
2014
Q2
$85.8M Sell
2,298,510
-882,102
-28% -$33.2M 0.09% 172
2014
Q1
$110M Sell
3,180,612
-525,963
-14% -$18.2M 0.12% 135
2013
Q4
$122M Buy
3,706,575
+1,709,622
+86% +$61M 0.12% 124
2013
Q3
$72.7M Buy
1,996,953
+1,128,894
+130% +$44M 0.09% 196
2013
Q2
$35.9M Buy
+868,059
New +$39.6M 0.04% 366

Other funds holding DOC

Barclays's DOC Position: Q2 2026 in Review

Barclays reduced its Healthpeak Properties (DOC) stake by 70% in Q2 2026, selling an estimated $34.1M and leaving 769,429 shares worth $16.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Barclays first reported a position in DOC in Q2 2013 and has held it in 44 quarters since. The position peaked at $122M in Q4 2013. 759 funds tracked by Wall St. Rank hold DOC as of Q2 2026.

  • Barclays held 769,429 shares of Healthpeak Properties worth $16.5M as of Q2 2026.
  • Barclays sold 1,828,888 Healthpeak Properties shares in Q2 2026, an estimated $34.1M.
  • Healthpeak Properties made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1231 holding.
  • Barclays first reported a position in Healthpeak Properties in Q2 2013 and has held it in 44 quarters since.
  • Barclays's Healthpeak Properties position peaked at $122M in Q4 2013.
  • 759 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.